Document ID: chunk:federal_register_of_legislation:C2022C00026:clause:9_1:p2
Version: federal_register_of_legislation:C2022C00026
Segment Type: clause
Provision Reference: sch 9 cl 1 (pt 2/2)
Character Range: 66616–68915

renum = renumbered
effect                                          rep = repealed
F = Federal Register of Legislation             rs = repealed and substituted
gaz = gazette                                   s = section(s)/subsection(s)
LA = Legislation Act 2003                       Sch = Schedule(s)
LIA = Legislative Instruments Act 2003          Sdiv = Subdivision(s)
(md) = misdescribed amendment can be given      SLI = Select Legislative Instrument
effect                                          SR = Statutory Rules
(md not incorp) = misdescribed amendment        Sub‑Ch = Sub‑Chapter(s)
cannot be given effect                          SubPt = Subpart(s)
mod = modified/modification                     underlining = whole or part not
No. = Number(s)                                 commenced or to be commenced

Endnote 3—Legislation history

Act                                                                                     Number and year  Assent       Commencement                                                                                                                                Application, saving and transitional provisions
National Health Amendment (Pharmaceutical Benefits—Budget and Other Measures) Act 2018  1, 2018          20 Feb 2018  Sch 1 (items 1–47): 1 Oct 2018 (s 2(1) item 2)
                                                                                                                      Sch 1 (items 48–87), Sch 2 (items 19, 20), Sch 3 (items 8–12) and Sch 4 (items 9–15): repealed before commencing (s 2(1) items 3, 5, 7, 9)
                                                                                                                      Sch 2 (items 1–18), Sch 3 (items 1–7), Sch 4 (items 1–8) and Sch 5–9: 21 Feb 2018 (s 2(1) items 4, 6, 8, 10)
                                                                                                                      Remainder: 20 Feb 2018 (s 2(1) item 1)
National Health Amendment (Enhancing the Pharmaceutical Benefits Scheme) Act 2021       139, 2021        13 Dec 2021  Sch 1 (items 1–3A): 14 Dec 2021 (s 2(1) item 2)                                                                                             —

Endnote 4—Amendment history

Provision affected         How affected